Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly
Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly

This week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals. The news jolted the health care sector, which fell by 2.74% over the

Nur Transparenz und Rechenschaftspflicht können das CERN retten: Milliardenverschwendung stoppen, lebensrettende Innovationen ermöglichen
Nur Transparenz und Rechenschaftspflicht können das CERN retten: Milliardenverschwendung stoppen, lebensrettende Innovationen ermöglichen

DALLAS, July 04, 2025 (GLOBE NEWSWIRE) -- Die Crosetto Foundation for the Reduction of Cancer Deaths, eine anerkannte gemeinnützige Organisation, richtet einen „dringenden Appell an die Mitglieder

3 Health Insurance Stocks Holding Green in Market Turmoil
3 Health Insurance Stocks Holding Green in Market Turmoil

During the recent market turmoil, three healthcare stocks have performed very well. Those stocks are deeply involved in the health insurance industry. They reacted positively after President

BeiGene Aktie: Dossier zur Marktlage
BeiGene Aktie: Dossier zur Marktlage

Die BeiGene Aktie verzeichnete in den letzten Tagen einen moderaten Rückgang und liegt aktuell bei 234,00 Euro, was einem Minus von 4,10 Prozent innerhalb der letzten Woche entspricht. Dieser

BeiGene Stock: Top Executives Sell Shares Near Record High
BeiGene Stock: Top Executives Sell Shares Near Record High

BeiGene, a leading pharmaceutical company with strong growth potential, is experiencing significant share sales by its top management. CEO John Oyler has divested shares worth approximately €25

Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth

As 2025 approaches, several promising micro-cap stocks are gaining attention for their potential to disrupt key industries. These companies, though small in market size, are making significant

Why Amentum Holdings Stock Rocked the Market Today: https://g.foolcdn.com/editorial/images/844637/person-in-the-military-using-a-tablet-computer.jpg
Why Amentum Holdings Stock Rocked the Market Today

Just after market close on Monday, Amentum Holdings (NYSE: AMTM) posted its latest set of quarterly figures. This led to a bull stampede into the stock the following day, with eager investors

Amentum (AMTM) Q3 Revenue Jumps 66%
Amentum (AMTM) Q3 Revenue Jumps 66%

Amentum (NYSE:AMTM), a leading provider of engineering, technical, and mission support services to government and commercial customers, reported results for Q3 FY2025 on August 5, 2025. The earnings

CMS Energy (CMS) Q2 EPS Jumps 7.6%
CMS Energy (CMS) Q2 EPS Jumps 7.6%

CMS Energy (NYSE:CMS), a major Midwest utility company providing electricity and natural gas to Michigan, announced its second-quarter 2025 results on July 31, 2025. The company reported

Why Eli Lilly Stock Topped the Market Today
Why Eli Lilly Stock Topped the Market Today

Although mighty American pharmaceutical company Eli Lilly (NYSE: LLY) has a dizzying number of commercialized products, it's a recently approved medication that's attracted outsized attention

Dr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far.
Dr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far.

From TV star to powerful government official. That's the path taken by President Donald Trump and his new administrator of the Centers for Medicare and Medicaid Services (CMS) -- Dr. Mehmet Oz.

Oz

Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?

Few drugs have generated as much excitement as Novo Nordisk's (NYSE: NVO) Ozempic and Wegovy. The U.S. Food and Drug Administration (FDA) approved Ozempic in December 2017 for treating type 2

Magnolia Welcomes Tech Pioneer Luc Haldimann as New Board Chairman to Expand Global Growth and AI Strategy
Magnolia Welcomes Tech Pioneer Luc Haldimann as New Board Chairman to Expand Global Growth and AI Strategy

BASEL, CH / ACCESS Newswire / November 27, 2025 / Magnolia, a leading global Digital Experience Platform (DXP) provider, is excited to announce that renowned software entrepreneur and